Responding for rewarding brain stimulation: cocaine and isradipine plus naltrexone (Q42539715)

2 November 2017

title

Responding for rewarding brain stimulation: cocaine and isradipine plus naltrexone (English)

1 reference

2 November 2017

0 references

N G Pabello

1

1 reference

2 November 2017

C L Hubbell

2

1 reference

2 November 2017

C A Cavallaro

3

1 reference

2 November 2017

T M Barringer

4

1 reference

2 November 2017

J J Mendez

5

1 reference

2 November 2017

L D Reid

6

1 reference

2 November 2017

language of work or name

English

0 references

publication date

1 October 1998

1 reference

Pharmacology, Biochemistry and Behavior

2 November 2017

published in

1 reference

2 November 2017

volume

61

1 reference

2 November 2017

issue

2

1 reference

2 November 2017

page(s)

181-192

1 reference

A controlled trial of fluoxetine in crack cocaine dependence.

2 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900084-7

7 January 2021

Opioidergic modulation of cocaine conditioned place preferences.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900084-7

7 January 2021

Blockade of cocaine-induced conditioned place preference: relevance to cocaine abuse therapeutics

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900084-7

7 January 2021

Isradipine combined with naltrexone persistently reduces the reward-relevant effects of cocaine and alcohol

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900084-7

7 January 2021

Enhancement by cocaine of intra-cranial self-stimulation in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900084-7

7 January 2021

Opioids and rewarding brain stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900084-7

7 January 2021

Isradipine and other calcium channel antagonists attenuate ethanol consumption in ethanol-preferring rats

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900084-7

7 January 2021

Isradipine and naltrexone in combination with isradipine interact with a period of abstinence to reduce rats' intakes of an alcoholic beverage

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900084-7

7 January 2021

Opioid blockade attenuates acquisition and expression of cocaine-induced place preference conditioning in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900084-7

7 January 2021

Isradipine blocks cocaine's ability to facilitate pressing for intracranial stimulation.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900084-7

7 January 2021

Fluoxetine is ineffective for treatment of cocaine dependence or concurrent opiate and cocaine dependence: two placebo-controlled double-blind trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900084-7

7 January 2021

Nimodipine improves information processing in substance abusers.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900084-7

7 January 2021

The effects of nimodipine on the EEG of substance abusers.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900084-7

7 January 2021

Opioid mediation of cocaine-induced hyperactivity and reinforcement

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900084-7

7 January 2021

Blockade by naloxone of cocaine-induced hyperactivity, reverse tolerance and conditioned place preference in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900084-7

7 January 2021

Effects of heroin on lever pressing for intracranial self-stimulation, food and water in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900084-7

7 January 2021

Naloxone inhibits the reinforcing and motivational aspects of cocaine addiction in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900084-7

7 January 2021

Calcium antagonists isradipine and nimodipine suppress cocaine and morphine intravenous self-administration in drug-naive mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900084-7

7 January 2021

Desmethylimipramine attenuates cocaine withdrawal in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900084-7

7 January 2021

Effects of the calcium antagonist isradipine on cocaine intravenous self-administration in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900084-7

7 January 2021

Naltrexone in the treatment of alcoholism: a clinical review

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900084-7

7 January 2021

Hypothalamic substrates of reward.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900084-7

7 January 2021

Effects of lesions in medial forebrain bundle on self-stimulation behavior

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900084-7

7 January 2021

Naltrexone and coping skills therapy for alcohol dependence. A controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900084-7

7 January 2021

The calcium antagonist PN 200-110 inhibits the reinforcing properties of cocaine

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900084-7

7 January 2021

Isradipine suppresses amphetamine-induced conditioned place preference and locomotor stimulation in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900084-7

7 January 2021

Endogenous opioids and alcohol dependence: opioid alkaloids and the propensity to drink alcoholic beverages

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900084-7

7 January 2021

Naltrindole, a delta-opioid antagonist, blocks MDMA's ability to enhance pressing for rewarding brain stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900084-7

7 January 2021

Isradipine in combination with naltrexone as a medicine for treating cocaine abuse.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900084-7

7 January 2021

Platelet alpha-granule release in cocaine users

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900084-7

7 January 2021

Behavioral functions of nucleus accumbens dopamine: empirical and conceptual problems with the anhedonia hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900084-7

7 January 2021

Neurologic complications of cocaine abuse.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900084-7

7 January 2021

Cerebral abnormalities in cocaine abusers: demonstration by SPECT perfusion brain scintigraphy. Work in progress

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900084-7

7 January 2021

Cerebral blood flow in chronic cocaine users: a study with positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900084-7

7 January 2021

Naltrexone in the treatment of alcohol dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900084-7

7 January 2021

10.1016/S0091-3057(98)00084-7

Identifiers

DOI

1 reference

release_2jxjqe75erffdjvox7dfayqh5u

2 November 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/2jxjqe75erffdjvox7dfayqh5u

24 November 2022

mapped directly with Wikidata item

1 reference